<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Federal and state role in pharmacy compounding and reconstitution</title>
    <subTitle>exploring the right mix to protect patients : hearing before the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Eighth Congress, first session, on examining state and federal oversight to ensure the safety and quality of drug compounding--the process of mixing, combining, or altering ingredients to create a customized medication for an individual patient--by pharmacies, October 23, 2003</subTitle>
  </titleInfo>
  <name type="corporate">
    <namePart>United States</namePart>
    <namePart>Congress.</namePart>
    <namePart>Senate.</namePart>
    <namePart>Committee on Health, Education, Labor, and Pensions.</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="marc">bibliography</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">dcu</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Washington</placeTerm>
    </place>
    <publisher>U.S. G.P.O.</publisher>
    <publisher>For sale by the Supt. of Docs., U.S. G.P.O.</publisher>
    <dateIssued>2004</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">electronic</form>
    <extent>iii, 145 p. ill. 24 cm.</extent>
  </physicalDescription>
  <note>"Printed for the use of the Committee on Health, Education, Labor, and Pensions."</note>
  <note>Distributed to some depository libraries in microfiche.</note>
  <note>Title from resource itself.</note>
  <note>Includes bibliographical references.</note>
  <note>Also available via the World Wide Web</note>
  <subject>
    <geographicCode authority="marcgac">n-us---</geographicCode>
  </subject>
  <subject authority="lcsh">
    <topic>Drugs</topic>
    <topic>Dosage forms</topic>
    <geographic>United States</geographic>
    <topic>Evaluation</topic>
  </subject>
  <subject authority="lcsh">
    <topic>Pharmaceutical Industry</topic>
    <geographic>United States</geographic>
    <topic>Quality control</topic>
  </subject>
  <classification authority="sudocs">Y 4.L 11/4:S.HRG.108-378</classification>
  <classification authority="">Y 4.L 11/4:S.HRG.108-378</classification>
  <relatedItem type="series">
    <titleInfo>
      <title>S. hrg. 108-378</title>
    </titleInfo>
    <name type="corporate">
      <namePart>United States.</namePart>
      <namePart>Congress.</namePart>
      <namePart>Senate.</namePart>
      <namePart/>
    </name>
  </relatedItem>
  <identifier type="isbn">0160715229</identifier>
  <identifier type="stock number">552-070-31093-2</identifier>
  <recordInfo>
    <recordContentSource authority="marcorg">BUF</recordContentSource>
    <recordCreationDate encoding="marc">040505</recordCreationDate>
    <recordChangeDate encoding="iso8601">20160527193412.0</recordChangeDate>
    <recordIdentifier source="OCoLC">265932</recordIdentifier>
  </recordInfo>
</mods>
